Researchers from the Netherlands Institute for Neuroscience (NIN) have identified a small molecule that can be used to rejuvenate the …
Continue reading “Small molecule can rejuvenate the Alzheimer’s brain”
NervGen readies for NASDAQ listing and clinical trials of lead compound for nerve regeneration in 2021. With a unique nerve …
Continue reading “Nerve regeneration tech targets Alzheimer’s and Nasdaq”
High doses of cannabidiol restores protein function to reduce beta-amyloid plaques in Alzheimer’s. Alzheimer’s disease is a neurodegenerative disease that …
Continue reading “CBD improves cognition in Alzheimer’s model”
Professor José Viña on early detection of Alzheimer’s and reasons to be hopeful. Professor Viña is head of the successful …
Continue reading “Light at the end of the Alzheimer’s tunnel”
New research finds being overweight is an additional burden on brain health – and it may exacerbate Alzheimer’s disease. Researchers …
Continue reading “Obesity may exacerbate the effects of Alzheimer’s”
European Patent Office grants Swedish biotech European patent for novel antibodies for Alzheimer’s therapy. Stockholm-based BioArctic announced today that the European …
Continue reading “BioArctic receives European patent for Alzheimer’s antibodies”
Incorporating biomarkers into the research definition of Alzheimer’s disease should lead to delayed progression, better treatment and new criteria for …
Continue reading “Defining Alzheimer’s by biomarkers could improve clinical trials”
This Longevity category product approval will bode well for our sector and will make institutional investors take note. Biogen’s aducanumab, …
Continue reading “Biogen Alzheimer’s drug closer to FDA approval”
Stealthy anti-aging start-up kicks-off £2.6m fundraise to target both Alzheimer’s and advanced cosmetics. Many of the companies working in the …
Continue reading “Five Alarm Bio targets Alzheimer’s and skin aging”
